{"schema_version":"secwatch.filing_event.v1","accession":"0001032220-24-000048","form_type":"8-K","ticker":"MMS","cik":"0001032220","company_name":"MAXIMUS, INC.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.947964+00:00","generated_at":"2026-06-02T08:30:07.935652+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Maximus Q2 revenue up 11.7% to $1.35B, adjusted EPS $1.57; raises FY24 guidance","bullets":["Revenue $1.35B (+11.7% YoY); organic growth 12.6%; adjusted EPS $1.57 vs $0.81 prior year.","Raises FY24 guidance: revenue midpoint +$75M to $5.20B; adjusted EPS now $5.65-$5.85 (+$0.40).","U.S. Federal Services revenue +20.1% to $701.7M, operating margin 11.9%; VA MDE contracts exceeded production goals.","U.S. Services segment margin 14.0% (peak from Medicaid redeterminations); FY24 margin outlook ~13%.","Quarterly dividend $0.30/share payable May 31; net debt/EBITDA improved to 1.7x; repurchased 242k shares for $19.3M post-quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001032220-24-000048","json":"https://secwatch.observer/filing/0001032220-24-000048.json","markdown":"https://secwatch.observer/filing/0001032220-24-000048.md","text":"https://secwatch.observer/filing/0001032220-24-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1032220/000103222024000048/0001032220-24-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1032220/000103222024000048/mms-20240508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T08:30:07.935652+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d87ecfcbe1d9866719d8aa8ede925f5175291e1e","claim":"MAXIMUS, INC. reported three months ended March 31, 2024 results: revenue $1.35 billion, EPS $1.31. Guidance raised.","evidence_excerpt":"reported financial results for the three and six months ended March 31, 2024. Highlights for the second quarter of fiscal year 2024 include: • Revenue increased 11.7% to $1.35 billion, compared to $1.21 billion for the prior year period. Organic growth was 12.6% and driven by expanded programs in the domestic segments and resumed Medicaid-related activities. •","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1032220/000103222024000048/0001032220-24-000048-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$1.35 billion"},{"label":"EPS","value":"$1.31"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}